Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Heart transplant vs left ventricular assist device in heart transplant-eligible patients.

Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter MS.

Ann Thorac Surg. 2011 May;91(5):1330-3; discussion 1333-4. doi: 10.1016/j.athoracsur.2011.01.062. Epub 2011 Mar 24.

PMID:
21439545
2.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
3.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.

4.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

5.

Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.

Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH.

Ann Thorac Surg. 2013 Mar;95(3):870-5. doi: 10.1016/j.athoracsur.2012.10.080. Epub 2012 Dec 4.

PMID:
23218024
6.

Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience.

Vitali E, Lanfranconi M, Bruschi G, Russo C, Colombo T, Ribera E.

J Card Surg. 2003 Mar-Apr;18(2):107-13.

PMID:
12757336
7.

HeartMate left ventricular assist device as bridge to heart transplantation.

Koul B, Solem JO, Steen S, Casimir-Ahn H, Granfeldt H, Lönn UJ.

Ann Thorac Surg. 1998 Jun;65(6):1625-30.

PMID:
9647070
8.

How does successful bridging with ventricular assist device affect cardiac transplantation outcome?

Urban M, Pirk J, Dorazilova Z, Netuka I.

Interact Cardiovasc Thorac Surg. 2011 Oct;13(4):405-9. doi: 10.1510/icvts.2011.273722. Epub 2011 Jul 25. Review.

PMID:
21788304
9.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.

Circulation. 2007 Jul 31;116(5):497-505. Epub 2007 Jul 16.

10.

Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?

Allen JG, Kilic A, Weiss ES, Arnaoutakis GJ, George TJ, Shah AS, Conte JV.

Ann Thorac Surg. 2012 Dec;94(6):2017-24. doi: 10.1016/j.athoracsur.2012.06.009. Epub 2012 Aug 2.

PMID:
22858277
11.

The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.

Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):169-73. doi: 10.1016/j.jtcvs.2010.03.026. Epub 2010 May 7.

12.

Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.

Teuteberg JJ, Ewald GA, Adamson RM, Lietz K, Miller LW, Tatooles AJ, Kormos RL, Sundareswaran KS, Farrar DJ, Rogers JG.

J Am Coll Cardiol. 2012 Jul 3;60(1):44-51. doi: 10.1016/j.jacc.2012.02.032. Epub 2012 Apr 25.

13.

The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.

Assad-Kottner C, Chen D, Jahanyar J, Cordova F, Summers N, Loebe M, Merla R, Youker K, Torre-Amione G.

J Card Fail. 2008 Dec;14(10):839-43. doi: 10.1016/j.cardfail.2008.08.004. Epub 2008 Nov 5.

PMID:
19041047
14.

Bridge to transplant with the HeartMate device.

Piccione W Jr.

J Card Surg. 2001;16(4):272-9.

PMID:
11833700
15.

Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience.

Osaki S, Edwards NM, Johnson MR, Velez M, Munoz A, Lozonschi L, Murray MA, Proebstle AK, Kohmoto T.

J Heart Lung Transplant. 2009 Jun;28(6):591-7. doi: 10.1016/j.healun.2009.03.008. Epub 2009 May 5.

PMID:
19481020
16.

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk?

Williams M, Casher J, Joshi N, Hankinson T, Warren M, Oz M, Naka Y, Mancini D.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):436-41.

17.

Change in quality of life from after left ventricular assist device implantation to after heart transplantation.

Grady KL, Meyer PM, Dressler D, White-Williams C, Kaan A, Mattea A, Ormaza S, Chillcott S, Loo A, Todd B, Costanzo MR, Piccione W.

J Heart Lung Transplant. 2003 Nov;22(11):1254-67.

PMID:
14585387
18.

Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.

Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Yuzefpolskaya M, Mancini DM, Naka Y.

J Heart Lung Transplant. 2015 Jan;34(1):89-99. doi: 10.1016/j.healun.2014.09.007. Epub 2014 Sep 8.

PMID:
25444372
19.

Selection and management of ventricular assist device patients: the Muenster experience.

Deng MC, Weyand M, Hammel D, Schmid C, Kerber S, Schmidt C, Breithardt G, Scheld HH.

J Heart Lung Transplant. 2000 Aug;19(8 Suppl):S77-82.

PMID:
11016493
20.

The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.

Argenziano M, Catanese KA, Moazami N, Gardocki MT, Weinberg AD, Clavenna MW, Rose EA, Scully BE, Levin HR, Oz MC.

J Heart Lung Transplant. 1997 Aug;16(8):822-31.

PMID:
9286774

Supplemental Content

Support Center